In Brief
The mitochondrial Ca 2+ uniporter (MCU)
is a critical mediator of mitochondrial Ca 2+ import, but its physiologic and pathologic roles remain unclear. Kwong et al. report MCU's essential role in acute mitochondrial Ca 2+ uptake in the heart, where it augments momentary Ca 2+ -dependent mitochondrial metabolic output in response to elevated contractile demand.
SUMMARY
In the heart, augmented Ca 2+ fluxing drives contractility and ATP generation through mitochondrial Ca 2+ loading. Pathologic mitochondrial Ca 2+ overload with ischemic injury triggers mitochondrial permeability transition pore (MPTP) opening and cardiomyocyte death. Mitochondrial Ca 2+ uptake is primarily mediated by the mitochondrial Ca 2+ uniporter (MCU). Here, we generated mice with adult and cardiomyocyte-specific deletion of Mcu, which produced mitochondria refractory to acute Ca 2+ uptake, with impaired ATP production, and inhibited MPTP opening upon acute Ca 2+ challenge. Mice lacking Mcu in the adult heart were also protected from acute ischemia-reperfusion injury. However, resting/basal mitochondrial Ca 2+ levels were normal in hearts of Mcu-deleted mice, and mitochondria lacking MCU eventually loaded with Ca 2+ after stress stimulation. Indeed, Mcu-deleted mice were unable to immediately sprint on a treadmill unless warmed up for 30 min. Hence, MCU is a dedicated regulator of short-term mitochondrial Ca 2+ loading underlying a ''fight-or-flight'' response that acutely matches cardiac workload with ATP production.
INTRODUCTION
Under physiological conditions, mitochondrial Ca 2+ loading serves as a signal to enhance mitochondrial energetic output, either by directly binding and activating key dehydrogenases of the tricarboxylic acid cycle or by activation of the ATP synthase, thereby linking momentary cardiac contractile Ca 2+ cycling with metabolic output (Glancy and Balaban, 2012) . However, prolonged elevations of intracellular Ca 2+ can trigger mitochondrial permeability transition pore (MPTP) opening, mitochondrial dysfunction, and cardiomyocyte death (Kwong and Molkentin, 2015 across the mitochondrial inner membrane (Kamer et al., 2014) . The core complex is comprised of the Mcu gene product itself that forms the pore and the regulatory subunits MICU1, MICU2, EMRE, and MCUb (Kamer et al., 2014) . Specific inhibition of MCU with pharmacological agents such as ruthenium red and Ru360 (Matlib et al., 1998; Zazueta et al., 1999) as well as genetic ablation of MCU complex components blocks acute mitochondrial Ca 2+ influx (Baughman et al., 2011; De Stefani et al., 2011; Pan et al., 2013; Sancak et al., 2013) . MCU inhibition via drugs or RNAi also abrogates cell death in numerous in vitro models, presumably due to less Ca 2+ influx and reduced MPTP opening (Dessi et al., 1995; Groskreutz et al., 1992; Qiu et al., 2013) . Recently, viable mice were generated with global deletion of the Mcu gene (Pan et al., 2013) . Although mitochondria isolated from these animals had impaired acute Ca 2+ uptake, cardiac structure and function were unaffected. Moreover, whereas Ca 2+ -induced MPTP opening was abrogated in purified mitochondria lacking Mcu (Pan et al., 2013) , cardiac ischemic injury was not reduced as would be predicted from past results with Ru360 or ruthenium red (García-Rivas et al., 2006; Zhang et al., 2006) . More recently, Wu and colleagues used a cardiac-specific transgenic approach to overexpress a dominantnegative MCU protein in the heart and found that MCU function was required for cardiac pacemaker cell activity to increase heart rate following catecholamine stimulation (Wu et al., 2015) .
RESULTS
Deletion of MCU in the Heart Blocks Acute Mitochondrial Ca 2+ Uptake To examine the immediate functional effects of the MCU in the heart, the Mcu locus was targeted with loxP sites (fl) flanking exons 5 and 6 to generate a conditional loss-of-function allele ( ifen food for 4 weeks followed by an additional 6-week period to allow for MCU protein turnover ( Figure 1B together, these results demonstrate that MCU-mediated mitochondrial Ca 2+ import neither contributes to overall cardiac Ca 2+ cycling in the heart nor is it required to support normal cardiac function and adaptation with aging.
Mouse models with subtle perturbations in baseline cardiac metabolic function or metabolic reserve often display increased pathology under stress stimulation, such as with transverse aortic constriction (TAC) (Abel and Doenst, 2011; Arany et al., 2006; Smeets et al., 2008; Wu et al., 2012 Figure 2H ). All three groups of mice showed identical pathologic profiles in response to TAC (Figures 2I-2L Figure 3E ). Analyses of MPTP opening in permeabilized adult cardiomyocytes, as reflected by loss of mitochondrial membrane potential, showed inhibition with Mcu deletion, which was similar to cyclosporine A (CsA) treatment of WT control myocytes ( Figure 3F ). Importantly, expression of MPTP components such as CypD (cyclophilin D), VDAC (voltage-dependent anion channel), and ANT (adenine nucleotide translocator) were unaltered with Mcu deletion ( Figure 3G ). These results suggest that loss of MCU in the heart inhibits acute Ca 2+ -induced MPTP opening, resulting in decreased cardiomyocyte damage in response to ischemia-reperfusion injury.
MCU Is Required for Acute Mitochondrial Metabolic-Contraction Coupling
Oxygen consumption and ATP generation were examined in isolated mitochondria in response to acute Ca Figures 4A and 4B) . Furthermore, potential alternative pathways of oxidation such as reactive oxygen species (ROS) production, NADPH oxidation, superoxide dismutase 2 (SOD2) levels, and catalase activity were also unaltered with Mcu deletion ( Figure S2 ). However, whereas addition of exogenous Ca 2+ to Mcu fl/fl control mitochondria resulted in an approximate 2-fold increase in respiration and ATP production, this acute effect was blocked by both Mcu deletion and addition of Ru360 to WT control mitochondria ( Figures 4A and 4B ).
To further investigate the hypothesis that MCU is mostly dedicated to short-term mitochondrial Ca 2+ regulation, we had to employ an intact system that could sustain extended measurements, such as isolated adult cardiac myocytes treated with the b-adrenergic receptor agonist isoproterenol. Similar to the -induced increase in mitochondrial respiration observed in isolated mitochondria ( Figure 4A ), isoproterenol treatment elicited an immediate increase in oxygen consumption in WT, but not Mcu-deleted, cardiomyocytes or with Ru360 pretreatment (Figures 4C and 4D) . However, over the course of 80 min, the isoproterenol-stimulated oxygen consumption of the Ru360-inhibited and Mcu-deleted myocytes slowly caught up to the rates observed in control myocytes ( Figures 4C and 4D) . These results suggest that MCU is specialized for acute matching of mitochondrial energy output with cardiac metabolic demands but that long-term Ca 2+ homeostasis can be achieved through other influx pathways. We also performed in vivo hemodynamic measurements on Figure 4G ).
DISCUSSION
In this study, we demonstrate that the role of MCU in the heart is to acutely match augmented cardiac work with mitochondrial energy output through mitochondrial Ca 2+ loading. Indeed, loss of MCU from the heart resulted in a selective inability to acutely respond to b-adrenergic receptor stimulation or maximal forced exercise by augmenting cardiac metabolic capacity as cardiomyocyte work is enhanced. However, MCU-deficient cardiomyocytes or deficient mice eventually catch up to controls in their contractile or metabolic performance, as does total Ca 2+ load in the mitochondria. The proposed model that MCU controls acute mitochondrial Ca 2+ entry is also supported by results observed under pathologic conditions. After cardiac ischemia-reperfusion injury, Mcu deletion in the adult heart was protective, a finding that recapitulates the cardioprotection observed with acute Ru360-mediated MCU inhibition in adult animals (García-Rivas et al., 2006; Zhang et al., 2006) . This result is also consistent with an acute regulatory role for MCU in loading mitochondria with excessive Ca 2+ leading to catastrophic MPTP opening and myocyte necrosis. Whereas cardioprotection was not observed with the constitutive Mcu deletion described earlier (Pan et al., 2013) , it should be noted that our targeting approach allowed us to examine uncompensated effects of MCU deletion in the adult heart, thereby circumventing the potential confounding metabolic alterations accompanying long-term and total body MCU loss. Indeed, total somatic Mcu-deleted mice displayed growth defects, lactic acidosis, and constitutive phosphorylation of the E1a subunit of the pyruvate dehydrogenase complex (Pan et al., 2013) . Such effects were not observed in our adult and cardiac-specific Mcu-deleted mice ( Figure S2 ). Our proposed model also suggests that baseline mitochondrial Ca 2+ levels could be regulated by one or more additional influx pathways, either with or independent of MCU. For example, Graier and colleagues showed that as many as five different Ca 2+ influx currents can be identified in mitoplasts (Jean-Quartier et al., 2012) , and a new current was identified in mitoplasts from cells with knockdown of MCU (Bondarenko et al., 2013) . In addition, Letm1 is an H + /Ca 2+ antiporter that can mediate energy-dependent Ca 2+ uptake into mitochondria at low cytosolic Ca 2+ concentration (Jiang et al., 2013) . Finally, both the ryanodine receptor 1 (RyR1) and transient receptor potential canonical 3 (TRPC3) have been shown to mediate Ca 2+ influx into mitochondria independent of the MCU (Beutner et al., 2001; Feng et al., 2013) . One known compensatory alteration that we did observe was a significant downregulation in mNCX protein expression and activity, which should partially offset the reduction in acute Ca 2+ influx, hence better maintaining overall calcium homeostasis. In summary, we conclude that MCU is the acute fight-or-flight mediator of Ca 2+ influx that facilitates immediate increases in mitochondrial metabolism and ATP production associated with augmented cardiac contractile performance.
EXPERIMENTAL PROCEDURES Animals
The Mcu gene-targeting strategy and generation of the Mcu chimeric mice was through the Howard Hughes Medical Institute Gene Targeting Core ( Figure S4 ). These same mice were also provided to Dr. John Elrod for their use in a cosubmitted manuscript published in this same issue (Luongo et al., 2015) . Homozygous Mcu fl/fl mice were bred to transgenic mice expressing the tamoxifen-inducible Cre recombinase under the control of the a-MHC promoter (Sohal et al., 2001 ). All animal experiments were approved and performed in accordance by Children's Hospital Medical Center's Institutional Animal Care and Use Committee.
Cardiac Functional Analyses, Surgical Procedures, and Treadmill Running Echocardiography was performed using a Hewlett Packard SONOS 5500 imaging system as previously described (Nakayama et al., 2009 ). The TAC model of cardiac pressure overload was performed as described previously (Kaiser et al., 2004) . Ischemia-reperfusion injury was performed as previously described (Wilkins et al., 2004) . Adult cardiac myocytes were isolated as previously described (Goonasekera et al., 2012) . The enforced sprinting protocols were performed using an Omni-Pacer LC4/M treadmill (Columbus Instruments International) and diagrammed in Figure S3 .
Respiration in Adult Cardiomyocytes
Respiration in adult cardiomyocytes was measured using a Seahorse XF24 Flux Analyzer (Seahorse Biosciences) as described in Readnower et al. (2012) .
Mitochondrial Isolation and Analyses
Cardiac mitochondria were isolated as previously described (Kwong et al., 2014) . Mitochondrial ATP synthesis rates were measured as described in Vives-Bauza et al. (2007) . Mitochondrial swelling assays were conducted as previously described (Kwong et al., 2014) .
Ca 2+ Sparks and Transients Measurements
Intact ventricular myocytes were loaded with Fluo-4 AM dye (5 mM Molecular Probes), and transients and sparks were recorded as previously described (Erickson et al., 2013; van Oort et al., 2010) .
Statistics
All results are presented as mean ± SEM. Statistical significance was determined by Student's t test, and p values < 0.05 were considered significant. 
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